The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal Medicine

• Status: Not yet recruiting
• Trial end date: 2022-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Conduct a clinical trial of integration of Chinese and Western medicine to evaluate whether the association of traditional Chinese medicine therapy has a remission effect on atopic dermatitis, and to explore the remission of lesions after an association of Chinese herbal medicine, and the correlation of syndrome differentiation types before and after treatment with Chinese and Western medicine, with a view to better understand the efficacy of atopic dermatitis in the treatment of the same disease in Traditional Chinese Medicine, and provide another option for patients with atopic dermatitis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Taipei Veterans General Hospital, Taiwan

Criteria

Inclusion Criteria:

• 6 years old to 30 years old.

• Diagnosis as an atopic dermatitis patient.

• The score of the SCORAD is over 20. (moderate to severe atopic dermatitis)

Exclusion Criteria:

• Secondary bacterial infections

• Received oral or intravenous steroid treatment, anti-biotics, phototherapy, or other immunosuppressive therapies in the previous 2 months.

• Received Chinese herbal medicine treatment or acupuncture.

• Pregnant woman or current breastfeeding.

• Who had catastrophes illness now or in the past must be avoided.

• Can not sign informed consent or can not communicate with the researcher.

• Abnormal liver enzymes.

• Abnormal kidney function tests (1.5 times higher than the upper normal limit)